Tuba Demirci Yildirim
Overview
Explore the profile of Tuba Demirci Yildirim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Demirci Yildirim T, Isguder R, Karacura E, Erez Y, Makay B, Onen F, et al.
Arch Rheumatol
. 2025 Mar;
39(4):662-669.
PMID: 40060127
Objectives: This study aimed to evaluate the rate of successful transitions, identify factors associated with early versus late transitions, and diagnosis and treatment changes after transition into adult rheumatology. Patients...
2.
Demirci Yildirim T, Kokoglu E, Coskun B, Yildirim D, Basaran E, Senel A, et al.
Clin Rheumatol
. 2024 Dec;
44(2):831-838.
PMID: 39718672
Objectives: To evaluate the incidence and characteristics of severe infections in rheumatic patients receiving biologic disease-modifying anti-rheumatic drugs (bDMARDs) after kidney transplantation. Methods: This multicenter, retrospective study included 38 patients...
3.
Ahmadzay Z, Heberg J, Jorgensen J, Ornbjerg L, Ostergaard M, Moller-Bisgaard S, et al.
Rheumatol Adv Pract
. 2024 Nov;
8(4):rkae135.
PMID: 39611201
Objectives: Real-world evidence is needed to inform treatment strategies for patients with PsA and axial SpA (axSpA) who have non-musculoskeletal manifestations (NMMs), various risk factors and comorbidities. International collaboration is...
4.
Demirci Yildirim T, Basibuyuk F, Birlik A
Rheumatol Int
. 2024 Oct;
44(12):3079-3085.
PMID: 39466382
The use of complementary and alternative medicine (CAM) has increased. Phytotherapy, also known as herbal medicine, is one of the CAM therapies that involves using medicinal plants and plant-derived substances....
5.
6.
Colak A, Kumral Z, Sezgin D, Omeroglu Simsek G, Demirci Yildirim T, Kis M, et al.
ESC Heart Fail
. 2024 Jul;
11(5):3332-3340.
PMID: 38961603
Aims: Right ventricular (RV) failure is one of the leading causes of death in patients with pulmonary hypertension (PH). Conventional echocardiographic parameters are not included in risk stratification and follow-up...
7.
Bilgin E, Demirci Yildirim T, Ulusoy B, Ogut T, Karabacak M, Cagdas O, et al.
Intern Emerg Med
. 2024 May;
19(5):1517.
PMID: 38814522
No abstract available.
8.
Kaymaz-Tahra S, Bayindir O, Ince B, Ozdemir Isik O, Kutu M, Karakas O, et al.
Semin Arthritis Rheum
. 2024 Apr;
66:152446.
PMID: 38669786
Background: Immunosuppressive (IS) agents are recommended for the first-line treatment of patients with active Takayasu's arteritis (TAK) together with glucocorticoids (GCs). However, there is limited data comparing the efficacy and...
9.
Bilgin E, Demirci Yildirim T, Ulusoy B, Ogut T, Karabacak M, Cagdas O, et al.
Intern Emerg Med
. 2024 Mar;
19(4):1025-1034.
PMID: 38553624
To investigate cancer incidence in patients with ANCA-associated vasculitis (AAV), compare it with the age/sex-specific cancer risk of the Turkish population, and explore independent risk factors associated with cancer. This...
10.
Koken Avsar A, Demirci Yildirim T, Sari I
Rheumatol Int
. 2024 Mar;
44(10):2227-2237.
PMID: 38488863
Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that is associated with systemic inflammatory conditions. Currently, there is no universally accepted standard therapy for PG, but immunosuppressive (IS) treatment seems...